Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma
Authors:
- Joni LeppänenJLJoni Leppänen
- Olli HelminenOHOlli Helminen
- Heikki HuhtaHHHeikki Huhta
- Joonas H. KauppilaJKJoonas H. Kauppila
- Joel IsohookanaJIJoel Isohookana
- Kirsi-Maria HaapasaariKHKirsi-Maria Haapasaari
- Seppo ParkkilaSPSeppo Parkkila
- Juha SaarnioJSJuha Saarnio
- Petri P. LehenkariPLPetri P. Lehenkari
- Tuomo J. KarttunenTKTuomo J. Karttunen
Open Access
- 4 July 2018
- journal article
- research article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 16 (1) , 1-9
Abstract
HIF-1alpha and CAIX proteins are commonly expressed under hypoxic conditions, but other regulatory factors have been described as well. Pancreatic ductal adenocarcinoma (PDAC) is characterized by hypoxia and strong stromal reaction and has a dismal prognosis with the currently available treatment modalities. We investigated the expression and prognostic role of HIF-1alpha and CAIX in PDAC series from Northern Finland (n = 69) using immunohistochemistry. In our PDAC cases, 95 and 85% showed HIF-1alpha and CAIX expression, respectively. Low HIF-1alpha expression correlated with poor prognosis, and multivariate analysis identified weak HIF-1alpha intensity as an independent prognostic factor for PDAC-specific deaths (HR 2.176, 95% CI 1.216–3.893; p = 0.009). There was no correlation between HIF-1alpha and CAIX expression levels, and the latter did not relate with survival. Our findings are in contrast with previous research by finding an association between low HIF-1alpha and poor prognosis. The biological mechanisms remain speculative, but such an unexpected relation with prognosis and absence of correlation between HIF-1alpha and CAIX suggests that the prognostic association of HIF-1alpha may not directly be linked with hypoxia. Accordingly, the role of HIF-1alpha might be more complex than previously thought and the use of this marker as a hypoxia-related prognostic factor should be addressed with caution.Keywords
Funding Information
- Pohjois-Pohjanmaan Rahasto
- Suomen Lääketieteen Säätiö
- Emil Aaltosen Säätiö
- Sigrid Juséliuksen Säätiö
- Thelma Mäkikyrö Foundation
- Orionin Tutkimussäätiö
- Päivikki ja Sakari Sohlbergin Säätiö
This publication has 60 references indexed in Scilit:
- Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinomaBMC Surgery, 2013
- HIF1-Alpha Expression Predicts Survival of Patients with Squamous Cell Carcinoma of the Oral CavityPLOS ONE, 2012
- Hypoxia-Inducible Factor-1α Regulates Chemotactic Migration of Pancreatic Ductal Adenocarcinoma Cells through Directly Transactivating the CX3CR1 GenePLOS ONE, 2012
- Expression and significance of TLR4 and HIF-1α in pancreatic ductal adenocarcinomaWorld Journal of Gastroenterology, 2010
- Expression of Hypoxia-Inducible Factor-1α, Histone Deacetylase 1, and Metastasis-Associated Protein 1 in Pancreatic CarcinomaPancreas, 2008
- Hypoxia: A key regulator of angiogenesis in cancerCancer and Metastasis Reviews, 2007
- Differential prognostic impact of hypoxia induced and diffuse HIF-1α expression in invasive breast cancerJournal of Clinical Pathology, 2005
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- Clinicopathological significance of hypoxia‐inducible factor‐1α expression in human pancreatic carcinomaHistopathology, 2003
- Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinomaCancer, 2003